» Articles » PMID: 16413501

Direct Chitosan-mediated Gene Delivery to the Rabbit Knee Joints in Vitro and in Vivo

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2006 Jan 18
PMID 16413501
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Chitosan vector system is expected to be useful for direct gene therapy for joint disease. This study first sought to confirm that foreign genes can be transferred to articular chondrocytes in primary culture. Next, chitosan-DNA nanoparticles containing IL-1Ra or IL-10 gene were injected directly into the knee joint cavities of osteoarthritis rabbits to clarify the in vivo transfer availability of the chitosan vectors. Clear expression of IL-1Ra was detected in the knee joint synovial fluid of the chitosan IL-1Ra-injected group. While no expression was detected in the chitosan IL-10-injected group, this demonstrates that the transfection efficiency of chitosan-DNA nanoparticles was closely related to the type of the gene product. A significant reduction was also noted in the severity of histologic cartilage lesions in the group that received the chitosan IL-1Ra injection. This avenue may therefore represent a promising future treatment for osteoarthritis.

Citing Articles

Therapeutic Controlled Release Strategies for Human Osteoarthritis.

Wang D, Liu W, Venkatesan J, Madry H, Cucchiarini M Adv Healthc Mater. 2024; 14(2):e2402737.

PMID: 39506433 PMC: 11730424. DOI: 10.1002/adhm.202402737.


Interleukins, growth factors, and transcription factors are key targets for gene therapy in osteoarthritis: A scoping review.

Uebelhoer M, Lambert C, Grisart J, Guse K, Plutizki S, Henrotin Y Front Med (Lausanne). 2023; 10:1148623.

PMID: 37077668 PMC: 10106745. DOI: 10.3389/fmed.2023.1148623.


Polymeric Nanoparticles for Drug Delivery in Osteoarthritis.

Pontes A, Welting T, Rip J, Creemers L Pharmaceutics. 2022; 14(12).

PMID: 36559133 PMC: 9788411. DOI: 10.3390/pharmaceutics14122639.


Nanotechnological Strategies for Osteoarthritis Diagnosis, Monitoring, Clinical Management, and Regenerative Medicine: Recent Advances and Future Opportunities.

Mohammadinejad R, Ashrafizadeh M, Pardakhty A, Uzieliene I, Denkovskij J, Bernotiene E Curr Rheumatol Rep. 2020; 22(4):12.

PMID: 32248371 PMC: 7128005. DOI: 10.1007/s11926-020-0884-z.


Inflammation-Modulating Hydrogels for Osteoarthritis Cartilage Tissue Engineering.

Koh R, Jin Y, Kim J, Hwang N Cells. 2020; 9(2).

PMID: 32059502 PMC: 7072320. DOI: 10.3390/cells9020419.